Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
508
-
Total 13F shares, excl. options
-
67.9M
-
Shares change
-
+1.85M
-
Total reported value, excl. options
-
$15.5B
-
Value change
-
+$456M
-
Put/Call ratio
-
0.56
-
Number of buys
-
286
-
Number of sells
-
-214
-
Price
-
$227.17
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2020
579 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2020.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 508 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.9M shares
of 71.9M outstanding shares and own 94.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.62M shares), BlackRock Inc. (6.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.29M shares), FRANKLIN RESOURCES INC (4.09M shares), STATE STREET CORP (3.48M shares), Neuberger Berman Group LLC (1.95M shares), WCM INVESTMENT MANAGEMENT, LLC (1.56M shares), BAMCO INC /NY/ (1.44M shares), Artisan Partners Limited Partnership (1.36M shares), and Durable Capital Partners LP (1.24M shares).
This table shows the top 508 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.